Associate Professor Muyderman’s qualifications ranges from a certificate in Psychiatry (1984), B.Nursing (1991). A MD and a PhD in Neuroscience (Goteborg University, Sweden). Dr Muyderman gained his licence to practise medicine 1998 (Sweden and EU) and was awarded a combined research/speciality training position in Neurology, Neuro-rehabilitation and Cardiology at the Sahlgrenska University Hospital in Gothenburg, Sweden the same year.

After post-doctoral studies at Flinders and clinical specialist training in Sweden he was awarded a 5-year Flinders Mary Overton research fellow ship from Flinders Medical Foundation (20050. The fellowship resulted in several publications, two PhD students brought to completion, several graduated honours students and a three-year NHMRC project grant. Dr Muyderman was appointed a full-time permanent academic position in 2010 in Medical Biochemistry.

The focus of Dr Muyderman’s research was on the role of oxidative damage in neurodegenerative diseases. His work has so far attracted > 1400 citations with a G-index of 37. From 2014 he focussed on medical education as an alternative to research and clinical work. In this role he coordinated the first 9 units of the medical program for several years. He was a member of the medical course directorate, actively participated in accreditation processes for the medical course and contributed to curriculum and assessment development. Between 2016 and 2019 he was the academic lead for a 18-unit, 4 year longitudinal research program in the Medical Program. In this role he promoted the program to various stakeholders and facilitated inter-institutional research collaborations between FMC/FUSA/RDH/Menzies (NT) and rural SA and NT. He also worked with SAHLN Office of research and Central Australia on issues related to governance and research ethics. Dr Muyderman’s position was de-established in February 2019 and he is currently holding Academic Status as an Associate Professor at the College of Medicine and Public Health.